303 related articles for article (PubMed ID: 28487391)
1. Functional Characterization of the
Kessler T; Wobst J; Wolf B; Eckhold J; Vilne B; Hollstein R; von Ameln S; Dang TA; Sager HB; Moritz Rumpf P; Aherrahrou R; Kastrati A; Björkegren JLM; Erdmann J; Lusis AJ; Civelek M; Kaiser FJ; Schunkert H
Circulation; 2017 Aug; 136(5):476-489. PubMed ID: 28487391
[TBL] [Abstract][Full Text] [Related]
2. Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants.
Wobst J; von Ameln S; Wolf B; Wierer M; Dang TA; Sager HB; Tennstedt S; Hengstenberg C; Koesling D; Friebe A; Braun SL; Erdmann J; Schunkert H; Kessler T
Basic Res Cardiol; 2016 Jul; 111(4):51. PubMed ID: 27342234
[TBL] [Abstract][Full Text] [Related]
3. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.
Kessler T; Wolf B; Eriksson N; Kofink D; Mahmoodi BK; Rai H; Tragante V; Åkerblom A; Becker RC; Bernlochner I; Bopp R; James S; Katus HA; Mayer K; Munz M; Nordio F; O'Donoghue ML; Sager HB; Sibbing D; Solakov L; Storey RF; Wobst J; Asselbergs FW; Byrne RA; Erdmann J; Koenig W; Laugwitz KL; Ten Berg JM; Wallentin L; Kastrati A; Schunkert H
Cardiovasc Res; 2019 Aug; 115(10):1512-1518. PubMed ID: 30768153
[TBL] [Abstract][Full Text] [Related]
4. Proatherosclerotic Effect of the α1-Subunit of Soluble Guanylyl Cyclase by Promoting Smooth Muscle Phenotypic Switching.
Segura-Puimedon M; Mergia E; Al-Hasani J; Aherrahrou R; Stoelting S; Kremer F; Freyer J; Koesling D; Erdmann J; Schunkert H; de Wit C; Aherrahrou Z
Am J Pathol; 2016 Aug; 186(8):2220-2231. PubMed ID: 27315776
[TBL] [Abstract][Full Text] [Related]
5. Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
Erdmann J; Stark K; Esslinger UB; Rumpf PM; Koesling D; de Wit C; Kaiser FJ; Braunholz D; Medack A; Fischer M; Zimmermann ME; Tennstedt S; Graf E; Eck S; Aherrahrou Z; Nahrstaedt J; Willenborg C; Bruse P; Brænne I; Nöthen MM; Hofmann P; Braund PS; Mergia E; Reinhard W; Burgdorf C; Schreiber S; Balmforth AJ; Hall AS; Bertram L; Steinhagen-Thiessen E; Li SC; März W; Reilly M; Kathiresan S; McPherson R; Walter U; ; Ott J; Samani NJ; Strom TM; Meitinger T; Hengstenberg C; Schunkert H
Nature; 2013 Dec; 504(7480):432-6. PubMed ID: 24213632
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling.
Emdin CA; Khera AV; Klarin D; Natarajan P; Zekavat SM; Nomura A; Haas M; Aragam K; Ardissino D; Wilson JG; Schunkert H; McPherson R; Watkins H; Elosua R; Bown MJ; Samani NJ; Baber U; Erdmann J; Gormley P; Palotie A; Stitziel NO; Gupta N; Danesh J; Saleheen D; Gabriel S; Kathiresan S
Circulation; 2018 Jan; 137(3):222-232. PubMed ID: 28982690
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin.
Hall KT; Kessler T; Buring JE; Passow D; Sesso HD; Zee RYL; Ridker PM; Chasman DI; Schunkert H
Eur Heart J; 2019 Nov; 40(41):3385-3392. PubMed ID: 31228190
[TBL] [Abstract][Full Text] [Related]
8. FoxO4 controls sGCβ transcription in vascular smooth muscle.
Galley JC; Miller MP; Sanker S; Liu M; Sharina I; Martin E; Gomez D; Straub AC
Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H417-H426. PubMed ID: 35089807
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of Forkhead Box Subclass O Transcription Factors Elicits Loss of Soluble Guanylyl Cyclase Expression.
Galley JC; Durgin BG; Miller MP; Hahn SA; Yuan S; Wood KC; Straub AC
Mol Pharmacol; 2019 Jun; 95(6):629-637. PubMed ID: 30988014
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
11. Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
Hervé D; Philippi A; Belbouab R; Zerah M; Chabrier S; Collardeau-Frachon S; Bergametti F; Essongue A; Berrou E; Krivosic V; Sainte-Rose C; Houdart E; Adam F; Billiemaz K; Lebret M; Roman S; Passemard S; Boulday G; Delaforge A; Guey S; Dray X; Chabriat H; Brouckaert P; Bryckaert M; Tournier-Lasserve E
Am J Hum Genet; 2014 Mar; 94(3):385-94. PubMed ID: 24581742
[TBL] [Abstract][Full Text] [Related]
12. Functional Analysis of a Novel Genome-Wide Association Study Signal in SMAD3 That Confers Protection From Coronary Artery Disease.
Turner AW; Martinuk A; Silva A; Lau P; Nikpay M; Eriksson P; Folkersen L; Perisic L; Hedin U; Soubeyrand S; McPherson R
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):972-83. PubMed ID: 26966274
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of soluble guanylyl cyclase subunits and PDE5A shRNA to elevate cellular cGMP level: A potential gene therapy for myocardial cell death.
Jing G; Xia Z; Lei Q
Technol Health Care; 2023; 31(3):901-910. PubMed ID: 36442224
[TBL] [Abstract][Full Text] [Related]
14. Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/β-catenin inhibition.
De Pauw A; Massion P; Sekkali B; Andre E; Dubroca C; Kmecova J; Bouzin C; Friart A; Sibille C; Gilon P; De Mulder D; Esfahani H; Strapart A; Martherus R; Payen V; Sonveaux P; Brouckaert P; Janssens S; Balligand JL
Cardiovasc Res; 2016 Oct; 112(1):478-90. PubMed ID: 27520736
[TBL] [Abstract][Full Text] [Related]
15. 9p21.3 Coronary Artery Disease Risk Variants Disrupt TEAD Transcription Factor-Dependent Transforming Growth Factor β Regulation of p16 Expression in Human Aortic Smooth Muscle Cells.
Almontashiri NA; Antoine D; Zhou X; Vilmundarson RO; Zhang SX; Hao KN; Chen HH; Stewart AF
Circulation; 2015 Nov; 132(21):1969-78. PubMed ID: 26487755
[TBL] [Abstract][Full Text] [Related]
16. Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.
Guey S; Hervé D; Kossorotoff M; Ha G; Aloui C; Bergametti F; Arnould M; Guenou H; Hadjadj J; Dubois Teklali F; Riant F; Balligand JL; Uzan G; Villoutreix BO; Tournier-Lasserve E
Hum Genomics; 2023 Mar; 17(1):24. PubMed ID: 36941667
[TBL] [Abstract][Full Text] [Related]
17. α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlanders.
Wilkins MR; Aldashev AA; Wharton J; Rhodes CJ; Vandrovcova J; Kasperaviciute D; Bhosle SG; Mueller M; Geschka S; Rison S; Kojonazarov B; Morrell NW; Neidhardt I; Surmeli NB; Aitman TJ; Stasch JP; Behrends S; Marletta MA
Circ Cardiovasc Genet; 2014 Dec; 7(6):920-9. PubMed ID: 25373139
[TBL] [Abstract][Full Text] [Related]
18. Associations between GUCY1A3 genetic polymorphisms and large artery atherosclerotic stroke risk in Chinese Han population: a case-control study.
Li JL; Liu LY; Jiang DD; Jiang YY; Zhou GQ; Mo DC; Luo M
Lipids Health Dis; 2019 Dec; 18(1):233. PubMed ID: 31883534
[TBL] [Abstract][Full Text] [Related]
19. Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway.
Rippe C; Zhu B; Krawczyk KK; Bavel EV; Albinsson S; Sjölund J; Bakker ENTP; Swärd K
Sci Rep; 2017 May; 7(1):1334. PubMed ID: 28465505
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
Filippov G; Bloch DB; Bloch KD
J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
